Metabolic Dysfunction-associated Steatotic Liver Disease
Gastroenterology
1
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
GS
Gilead SciencesFOSTER CITY, CA
2 programsDigital nutritional programN/A1 trial
Digital nutritional programN/A
Active Trials
Trial Timeline
Clinical trial activity over time
2024
2025
2026
2027
2028
RegeneronALN-CIDEB
Gilead SciencesDigital nutritional program
GuerbetGuerbet Liver Fibrosis
Clinical Trials (3)
Total enrollment: 266 patients across 3 trials
A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)
Start: Apr 2025Est. completion: Mar 2027100 patients
Phase 1Recruiting
Effect on Body Weight Reduction of a Behavioral Intervention on Lifestyle Using a Digital Nutritional Program in People Living With HIV and Metabolic Dysfunction-associated Steatotic Liver Disease
Start: Apr 2025Est. completion: Feb 2028116 patients
N/AEnrolling By Invitation
Guerbet Liver Fibrosis
Start: Feb 2024Est. completion: Feb 202650 patients
N/AEnrolling By Invitation
Related Jobs in Gastroenterology
Specialty Representative, Gastroenterology – Minneapolis, Minnesota
AbbVie
Remote
8h ago
Key Account Director, Diagnostics and Research
Tempus
Remote
22h ago
$150K - $200K/yr
Experienced Clin Programmer
Johnson & Johnson
High Wycombe, Buckinghamshire, United Kingdom
22h ago
[Innovative Medicine] Director, Government Affairs and Policy Dept., Integrated Market Access Div.
Johnson & Johnson
Chiyoda, Tokyo, Japan
22h ago
Analyst Accounting
Johnson & Johnson
Suzhou, Jiangsu, China
22h ago
Lead Product Security Engineer
Johnson & Johnson
Danvers, Massachusetts, United States of America
22h ago
$94K - $152K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 266 patients
3 companies competing in this space